Kuros Biosciences AG Nam.-Aktien SF 0,10

Sector and Industry

Healthcare, Healthcare Equipment

Performance (1Y)

21.46%

Market Cap

889.40 Mil.

P/E Ratio

498.73

Dividend Yield

0.00 %

Earnings per Share

0.06 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Abbott Laboratories185.26 Bil.39.29 Bil.33.69
-53.32 %
0.00
-
Intuitive Surgical Inc171.24 Bil.8.92 Bil.71.93
+17.90 %
0.00
-
Boston Scientific Corp120.40 Bil.17.79 Bil.49.17
+49.88 %
0.00
-
Stryker Corp.114.47 Bil.22.26 Bil.41.85
+3.99 %
0.00
-
Medtronic PLC90.93 Bil.31.27 Bil.22.35
-4.61 %
0.00
-
Siemens Healthineers AG51.40 Bil.23.38 Bil.24.04
+10.40 %
0.00
-
Hoya Corp48.59 Bil.5.43 Bil.35.69
+17.33 %
0.00
-
Becton Dickinson and Co.45.46 Bil.19.79 Bil.32.18
-3.33 %
0.00
-
Edwards Lifesciences Corp42.15 Bil.5.38 Bil.47.11
-27.44 %
0.00
-
Alcon AG33.20 Bil.9.24 Bil.38.41
-7.56 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE22.08 G0 Units
PRICE DETERMINATION TIME07/23/2026 / 09:46:42 PM
DAILY VOLUME (UNITS)50
DAILY HIGH / LOW22.5221.32
PREV. DAY'S PRICE22.54 (07/22)
CHANGE DAY BEFORE
-0.46
-2.04 %
52 WEEK HIGH / LOW36.55 (10/20)19.16 (06/22)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-0.39-0.120.060.270.63
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
--498.7380.0534.01
PRICE - BOOK RATIO
2.2613.7616.08--
PRICE - SALES RATIO
3.8010.519.38--
PRICE - CASH FLOW RATIO
-252.93---
Further Key Figures

Master Data

WKN
A2ALS5
ISIN
CH0325814116
SYMBOL
YTSN
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Cytos Biotechnology
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Swiss Franc
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Healthcare Equipment
NUMBER OF SHARES
39.46 Mil.
MARKET CAPITALISATION
889.40 Mil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-3.26 %
16.37 %
-9.04 %
-26.22 %
-21.46 %
--
-24.11 %
HIGH23.3224.1024.8033.0536.55--33.05
LOW20.8019.1819.1619.1619.16--19.16

Dividende

pro Aktie
Cytos Biotechnology does not deliver dividend information

Company profile

Kuros Biosciences Ltd. operates as biopharmaceutical company, which engages in developing products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals, and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment offers Fibrin-PTH, a drug-biologic combination which promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and by increasing the lifespan of bone-forming cells. The Legacy portfolio segment is involved in all other products that do not belong to the group's core business strategy. The company was founded by Didier Cowling in 2000 and is headquartered in Schlieren, Switzerland.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.